MEZEREUM (Seroyal USA)


Welcome to the PulseAid listing for the MEZEREUM drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Seroyal USA
NON-PROPRIETARY NAME: Mezereum
SUBSTANCE NAME: DAPHNE MEZEREUM BARK
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: GRANULE
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-12-09
END MARKETING DATE: 0000-00-00


MEZEREUM HUMAN OTC DRUG Details:

Item DescriptionMEZEREUM from Seroyal USA
LABELER NAME: Seroyal USA
DEA SCHEDULE:
ACTIVE STRENGTH: 1([hp_X]/1)
START MARKETING DATE: 2015-12-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62106-8435_267f96e2-fb23-2a3c-e054-00144ff8d46c
PRODUCT NDC: 62106-8435
APPLICATION NUMBER:

Other DAPHNE MEZEREUM BARK Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Laboratoires BoironMezereum
Natural Health SupplySkin Eruptions
Paramesh Banerji Life Sciences LLCMezereum 200C
Rxhomeo Private Limited d.b.a. Rxhomeo, IncMEZEREUM
Seroyal USAMEZEREUM
Washington Homeopathic ProductsMezereum